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(MPR) and Single Tablet Regimens (STR). Validated and self-reported questionnaires 
(ISS-QoL, EQ-5D-3L and CES-D) were administered to collect social and clinical data, 
QoL measure and adherence information, both at baseline and follow-up (6 months). 
The correlations between i) perceived QoL and the above mentioned variables, ii) 
determinants and/or predictors of the QoL, were investigated. Results: 300 ques-
tionnaires were delivered and 174 were completed. MPR and STR populations were 
comparable for all personal details, with similar immunological and virological 
effectiveness. Patients receiving STR declared a higher QoL than individuals using 
MPR (P= 0.004). Non-adherence, depression, lack of wellbeing and higher number 
of comorbidities lead to worse QoL (P< 0.05). The predictors of QoL in HIV-infected 
individuals were duration of HIV infection (P= 0.00), wellbeing measures (P= 0.01), 
years of treatment (P= 0.007) and viral load (P= 0.003). ConClusions: Although 
literature showed that QoL depends on CD4 count, the results of our study suggested 
that in the Italian setting, immunological effectiveness is not a determinant and a 
predictor of QoL variation. Regimen treatment impacts on adherence and compli-
ance: simplification strategies could improve QoL patients perception.
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objeCtives: To study the influence of symptom experience and clinical mark-
ers on a multidimensional Health-related quality of life (HRQL) questionnaire 
specific to HIV using sparse PLS regression and Canonical Correlation Analysis 
(RGCCA). Methods: Self-reports were collected during the Vespa2 national 
survey, including: the 8-dimension PROQOL-HIV questionnaire, a 22-symptom 
checklist, and 22 binary clinical indicators. Complete cases for all three blocks 
of data were considered in this analysis: N= 1524 patients undergoing ART, age = 
47, 77% men, 51% MSM, 80% undetectable viral load. Data were analysed using 
bootstrapped sparse PLS (HRQL and symptoms only) and RGCCA (three blocks), 
with hyper-parameters (number of components, κ , and L1 penalty, λ ) optimised 
through 10-fold cross-validation. The HRQL block was never penalised. Results: 
Sparse PLS (κ = 4, λ = 0.65) selected 15 symptoms where sexual dysfunction, lipod-
ystrophy, depression had the highest negative loadings on relevant dimensions 
of the PROQOL-HIV dimensions (sexual relationships, body changes, emotional 
distress). Fatigue, anxiety, and sleep disorder cross-loaded on all but the body 
changes dimension. Using three-block RGCCA (λ = 0.7), the top symptoms (loadings) 
on the first component (44% of average variance explained) were anxiety (0.52), 
depression (0.51), and fatigue (0.48), while gender (-0.68), chronic HCV (0.61) and 
living mode (0.30) were the most important clinical predictors. Model-based cluster 
analysis of first component scores highlighted four equal-size clusters of patients 
accounting for important individual factors: chronic HCV, MSM vs. women, living 
alone, disease duration. ConClusions: Using sparse multi-block modelling of 
HRQL, symptom experience, and clinical markers allows to study both variables 
relationships and individual profiles of respondents. Accounting for the differen-
tial impact of symptoms and clinical factors on several dimensions of a specific 
HRQL questionnaire provides interesting perspectives in health management and 
treatment monitoring for HIV patients.
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objeCtives: To validate a new international questionnaire to assess Health-
Related Quality of Life (HRQL) in patients living with HCV. Existing tools used in 
HCV were mostly generic and missing important concepts such as impact of the 
treatment. Methods: 660 HCV mono-infected or HIV co-infected patients included 
in a cross-sectional survey in 3 countries (France [59%], Brazil [30%], and Australia 
[11%]) completed paper- or internet-based version of 3 HRQL questionnaires and 
symptom, sociodemographic and biomedical checklist. Psychometric item analysis 
and factor analysis were used to reduce the original 72-item PROQOL-HVC question-
naire. Reliability (Cronbach’s alpha), convergent validity (EQ-5D, SF-12, symptoms), 
and clinical validity (biological markers) were assessed on the final version using 
correlation and two-group comparison at a fixed 5% level. Results: Sample char-
acteristics: 57% men, 52 years, 80% vocational level and higher, 35% living alone. 
Regarding comorbidities and treatment status: 35% co-infected with VIH (95% under 
ART), 15% not treated, 25% undergoing interferon, 35% ribavirine, 43% Direct-Acting 
Antivirals (35% without associated interferon); 27% depressive (71% treated). The 
PROQOL-HCV questionnaire was reduced to 38 items spanning 7 dimensions scored 
on a 100-point scale: Physical Health (PH, 6 items, α = 0.90), Emotional Health (EH, 
9 items, α = 0.93), Future Uncertainty (FU, 6 items, α = 0.79), Intimate Relationships 
(IR, 3 items, α = 0.86), Social Health (SH, 3 items, α = 0.47), Cognitive Functioning (CF, 
3 items, α = 0.80), and Treatment Impact (TI, 8 items, α = 0.61). Pearson correlations 
of PROQOL-HCV dimension with the EQ5-D (general health) and SF-12 mental and 
physical composites were in the acceptable range. The PH dimension was negatively 
correlated to the number of bothersome symptoms (p< 0.001). Lower HRQL (PH, EH, 
CF) was reported in women (p< 0.01), depressive patients (p< 0.001), patients under 
interferon (p< 0.01, except CF), patients without treatment (p< 0.01). ConClusions: 
PROQOL-HCV questionnaire is valid and contains new dimensions such as Intimate 
Relationship, Social Health and Treatment impact.
the time trade-off method. Results: The sample (N= 100) demographics were rep-
resentative of the general population of France by age, gender and education level. 
The stable HS had a utility value of 0.95. The disutility of the CNS side effects ranged 
from -0.09 (abnormal dreams) to -0.62 (suicidal thoughts) from the stable state. The 
disutility values for the other side effects were: -0.11 (headaches), -0.12 (attention 
difficulties, insomnia), -0.18 (somnolence), -0.19 (dizziness), -0.25 (balance and coor-
dination problems) and -0.37 (anxiety and depression). ConClusions: The results 
suggest CNS side effects cause significant burden and impact on HRQL. Society places 
particular value in avoiding AEs such as suicidal thoughts, anxiety and depression 
and balance and coordination problems. These utility values highlight the negative 
impact of AEs and can be used in economic evaluations.
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objeCtives: To assess knowledge, attitude and perception of Polio (Poliomyelitis) 
among general public in Pakistan and to recommend suitable measures in order to 
improve the awareness of this perilous disease. Methods: A cross-sectional study 
was conducted on a newly developed, validated and structured self-administered 
research tool and data was collected by interviews. Face and content validity of 
the research tool was done by various healthcare individuals including academics, 
physicians, pharmacists and senior nurses. The research tool was also piloted on 
15 healthcare providers in a different hospital before start of the study. A p-value 
< 0.05 was considered statistically significant. Results: The findings of the study 
revealed that out of 1250 participants, 87.5% were males while 12.5% were females. 
11.2% of the participants believed that vaccination was prohibited in religion, 85.4% 
participants were aware of Polio disease, and 84.5% believed that disease could 
be prevented by giving vaccines to children. 82.3% participants gave vaccine to 
their children whereas 55.2% knew the schedule of the vaccine for their children. 
This study also found that 88.8% of the participants wanted to eradicate disease 
from Pakistan. ConClusions: The results of the study revealed that people have 
adequate knowledge about Poliomyelitis and wanted to eradicate it from Pakistan 
by participating in vaccination activities but still there are few who believe that Polio 
vaccine cannot prevent the disease.
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objeCtives: In India, Human immunodeficiency virus (HIV) infected patients lacks 
knowledge on highly active antiretroviral therapy (HAART) leading to non-adherence.
The study was conducted to assess the effect of pharmacist counseling on HAART 
and Patient reported outcomes related to Knowledge, Attitude, Belief and Practice 
(KABP) behavior. Methods: A prospective study was conducted with Institutional 
Ethics Committee Approval, at tertiary care teaching hospital, from October 2011 to 
June 2012. People living with HIV (PLH) were counseled by a pharmacist with vali-
dated (KABP) questionnaires and data scores of (KABP) responses were assessed at 
the base-line, pre and post counseling.Counseling was on safe use of HAART, signifi-
cance of HAART adherence. Pearson chi-square test was used to compare baseline 
Pre- KABP and Post- KABP responses with follow-ups. Results: A total 120 PLH (89 
males, 31 females) were counseled. The PLH were counseled on tenofovir + emtricit-
abine + efavirenz followed by zidovudine + lamivudine + nevirapine therapy. At the 
baseline 94(78.3%) knew the mode of HIV transmission and 60(50%) were not aware 
about the content of HAART. Aftet pharmacist counseling, 58.3% (p< 0.001) of patients 
knew about the content of HAART. Knowledge score was (p< 0.001) higher in the 
literate group (51.7%) compared to Illiterate group (48.3%). Patients attitude, beliefs 
related to HAART, were found to be (p< 0.05) and 78% (p< 0.001) patients were aware 
that lifelong HAART therapy is needed. In comparison, from base line counseling 
responses of (33%) to post counseling responses of (67.5%) of PLH realized that HAART 
improves immunity ConClusions: Pharmacist counseling removed social stigma, 
and increased self-efficacy beliefs to maintain adherence to HAART.
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objeCtives: Psychological, social, wellbeing factors and adherence emerged as key 
issues for measuring the HIV-infected patients quality of life (QoL). In the literature, 
but in Italian evidences in particular, there is a lack of indication concerning i) a 
specific “country-oriented” QoL measure, ii) its relationship among immunological 
(CD4) and virological (VL) status and iii) determinants and predictors of HIV-patients 
QoL. The aim of the study was to examine the QoL, adherence, wellbeing, depression, 
CD4 and VL, in an Italian unselected cohort of patients receiving stable antiretroviral 
treatment. Methods: A multicenter, prospective study was conducted, involving 3 
Infectious Diseases centers in Lombardy Region. Two groups of patients were consid-
ered, depending on the therapeutic strategy characteristics: Multiple Pill Regimens 
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tablet regimen and avoidance of an increased heart attack risk. Not being tied to 
mealtime dosing was a lower priority.
INfectIoN – Health care use & Policy studies
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objeCtives: Antibiotics have played a magic role in controlling infectious diseases 
in humans. However their indiscriminate use and prescriptions have rendered over-
whelming level of pathogenic bacteria resistant, which has resulted in increased 
mortality, morbidity and increased rates of hospitalizations incurring significant 
economic losses. Self-medication and misprescription of antibiotics at pharmacy 
stores are one of the major contributory factors in speeding up this phenomenon of 
resistance in bacterial communities. The aim of this study was to survey and assess 
the unregulated and indiscriminate sale of antibiotics in pharmacy stores in Khyber-
Pakhtunkhwa province in Pakistan. Methods: In this study several pharmacy stores 
in two major cities, Mardan and Swabi, in Khyber-Pakhtunkhwa province in Pakistan 
were checked on two criteria; whether there were qualified and certified pharmacists 
available, and whether they demanded any doctor/ hospital prescription while giv-
ing antibiotics. Results: About 80 percent of the people sitting on the counter in 
pharmacies were not certified pharmacists, and 100 percent did not bother to demand 
any doctor’s prescription while selling antibiotics. ConClusions: This is an indica-
tion of an inevitable disaster to the healthcare system, which can potentially lead 
to enormous losses to human lives and economy. An urgent need of legislation on 
antibiotics therapy in Pakistan is the need of the day; otherwise we will be left with 
no choice than to surrender to deadly microbial diseases.
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objeCtives: A high level of vaccine acceptance is an important requirement for suc-
cessful vaccination programmes. Therefore, vaccine acceptance is a common criteria 
considered in national immunisation decision-making processes. This systematic 
review aimed to assess the acceptance of herpes zoster (HZ) vaccination among 
the target group (i.e. people aged 50 years and older) and physicians. Methods: A 
PubMed search was performed for identifying English and German language publica-
tions on studies assessing HZ vaccine acceptance published before June 2015. A study 
was included if it provided information on awareness, knowledge, attitudes and/or 
perceived barriers regarding HZ vaccination among people aged 50 years and older 
or physicians. Results: After the study selection process, 15 studies remained to be 
included in the review. Ten of these studies investigated aspects of vaccine acceptance 
in the target group. Five studies concentrated on the perspective of physicians. Almost 
all studies used quantitative research methods; one study used a qualitative design 
based on focus group interviews. Most of the interviewed patients and physicians 
attached great importance to the HZ vaccine. However, when compared to influenza 
and pneumococcal vaccination, HZ vaccination was considered as a less important 
clinical priority by physicians. From the perspective of the target group, the primary 
care physician’s recommendation was a crucial factor in reaching a high level of vac-
cine acceptance. The main barriers of vaccine acceptance were the price of the vac-
cine, concerns about side effects and the perception of low risk of HZ. ConClusions: 
This review identified several factors influencing the acceptance of HZ vaccination. 
Successful implementation of HZ vaccination might depend on the health care pro-
vider’s attitude, the reimbursement of costs and the target group’s knowledge on HZ.
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objeCtives: To describe patterns and factors influencing real-world management 
of Danish patients infected with Hepatitis C virus (HCV). Methods: From DANHEP, 
a national Danish HCV/HBV registry, we identified HCV genotype 1 or 4 patients 
initiating the following treatment strategies between 2011 and 2014 (excluding 
early access programs): 2nd and 1st generation direct-acting antivirals (2GDAA 
and 1GDAA), dual therapy (DT), or no treatment (NT). Patients could have ≥ 1 treat-
ment episode. We estimated proportion treated, treatment duration, and describe 
patients according to HCV strategy initiated. Results: Among 1,988 patients with 
7,209 treatment episodes (including NT), proportion of patients treated yearly was 
low (range: 0.9-4.2%) and lowest in 2013, just prior to 2GDAA market entry. In 2014, 
96.4% (53/55) of treatment episodes (excluding NT) were with 2GDAAs. Most 2GDAA 
treatments initiated were interferon-free (N= 44/53; 83.0%), with uptake highest 
for simeprevir-sofosbuvir (31/53; 58.5%) and sofosbuvir-daclatasvir (11/53; 20.8%) 
combination therapy. Average completed treatment duration (in weeks) with 
2GDAAs (13.8, SD= 5.4; N= 33) was shorter than for 1GDAAs (32.0, SD= 17.7; N= 102) 
and DT (32.2, SD= 17.9; N= 42), in accordance with approved treatment duration. 
Interferon-free 2GDAA treatment with ribavirin (16.6, SD= 4.7; N= 12) was longer 
than without ribavirin (12.0, SD= 4.4; N= 13); ribavirin may selectively be used for 
harder to treat patients as suggested by higher cirrhosis prevalence (76.9% vs. 56.5%) 
and previous treatment exposure (64.7% vs. 44.4%). Patients initiating 2GDAAs 
were more commonly cirrhotic (55.6% vs. 30.8% for 1GDAA, 35.3% for DT, 15.5% for 
NT) and previously treated (50.9% vs. 35.3% for 1GDAA, 26.2% for DT, 3.7% for NT) 
than initiators of other strategies, in line with Danish reimbursement criteria for 
2GDAAs. ConClusions: Proportion of patients treated remains low (< 5%), despite 
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objeCtives: Existing tools for sexual function are mostly focused to the erectile 
dysfunction and do not measure the domains important for patients living with 
HIV/AIDS (PLVHA) or HCV (PLVHC) such as stigma, fear of transmission, or type 
of sexual practices. Methods: An exploratory descriptive qualitative phenom-
enological study was conducted in France based on face to face interviews with 
PLVHA and/or PLVHC. Sample was selected to represent different medical, social 
and demographic situations. The open coding of the interviews allowed validat-
ing a book of 433 codes. They were organized into dimensions of the conceptual 
framework. Results: 28 interviews were conducted: 17 PLVHA, 8 PLVHC and 3 
co-infected. The median age was 48.5 years [29; 74] with 11 women, 6 men and 
1 transsexual. The transmission modes were homosexual (11), heterosexual (10), 
intravenous drug use (5) and blood transfusion (2). Majority of PLVHA (88.2 %) 
and all co-infected were under HIV treatment. The thematic coding revealed the 
following dimensions: HIV impact, sexuality (sexual life, practice, satisfaction 
and difficulties), prevention and HIV comprehensive care, partners, social life, 
psychological impact, internet use and perception discrepancies. Most of these 
concepts are new or bring more detail than the tools in current use. Men having 
sex with men population described specific topics such as stigma and substance 
use. Sexuality difficulties were diverse: problems of libido or erection, sexual 
performance and pleasure, reluctance to have sex, sexual intercourse in spite of 
oneself, fear of transmission or of contamination and difficulty of using condoms. 
The deterioration in the quality of sexual life was reflected in global sexual dis-
satisfaction. ConClusions: Sexual dysfunction in PLVHA and PLVHC is important 
and frequent. Qualitative analysis and description of the concepts have led to the 
creation of the framework of a future specific questionnaire.
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objeCtives: To understand the relationship between socio-demographic variables, 
clinical factors, highly active anti-retroviral therapy (HAART) and health related 
quality of life (QoL) in HIV-infected individuals participants in the IANUA mul-
ticenter study. Methods: Data relating to patients with HIV infection admitted 
to 3 infectious disease units in Genoa (Italy) between 2012 and 2014 are collected 
and analyzed. Univariate and multivariate association of demographic and clinical 
factors with QoL (computed using EQ-5D-3L) are examined. QoL determinants are 
assessed using a tobit model, while a logistic model is implemented in order to 
investigate the relation between specific patients characteristics and the likelihood 
of having higher QoL. Results: Results of the empirical modeling suggest that 
being Italian and having a job are positively associated with QoL, whereas being a 
female, taking other drugs in addition to anti-retroviral drugs and being subsidis-
ied are negatively related to QoL. Among clinical factors, last CD4 cell count level 
cannot be considered as significant predictor of QoL, while higher QoL seem to be 
defined by single tablet regimens. ConClusions: The study investigates the major 
determinants of QoL among HIV patients and the results provide some informative 
tools useful to improve strategies aiming at maximizing QoL. As monitoring of QoL is 
nowadays a priority for clinicians, further work will be based on “dynamic” analysis 
comparing QoL at the initial time and QoL at 6-months follow up.
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objeCtives: The objective was to estimate patient preferences for simplified treat-
ment regimens, amongst UK HIV patients currently treated with anti-retroviral 
therapy (ART). Methods: Data were collected via a prospective web-based survey 
(June to October 2014) comprising a discrete choice experiment. A d-efficient design 
was developed in Ngene comprising 12 hypothetical choices of two drug scenarios 
with five attributes (number of tablets (1 to 4), mealtime dosing, increased risk of 
heart attack or insomnia (yes/no), and monthly cost to the healthcare system (£500, 
£600, £750, £1000)). A steering committee of clinicians, nurses, pharmacists, patient 
group representatives and academics, guided the survey design which was tested by 
UK patients. The response patterns were analysed in STATA v13 using generalised 
multinomial logit models (GMNL), including scale heterogeneity multinomial logit, 
mixed logit and fixed-effect logit models. Willingness to pay (WTP) in GBP was used 
as a metric to quantify the strength of preference for each attribute. Results: 
Results: Responses were analysed for 278 UK patients currently receiving ART. 72.6% 
were men who have sex with men, 14.7% were female. Median age was 44 (range 
21-66) years, time since diagnosis 8 (0-30) years and 5 (0-27) years duration of treat-
ment. Across the models, the attributes were ranked similarly, though the range 
of WTP was more extreme for some models than others. Based on the best fitting 
model (GMNL with correlated random-effects), patients were most willing to pay 
for the avoidance of insomnia (£1083, 95% CI £500-£1664), then one tablet per day 
(£934, CI £461-£1406), avoidance of a heart attack (£589, CI £231-£947) then avoid-
ing mealtime dosing (£516, CI £242-£790). ConClusions: UK HIV patients have 
a strong preference for avoiding treatment related insomnia, followed by a single 
